Targeting pathways that modify RNA to deliver novel cancer therapeutics
Targeting pathways that modify RNA to deliver novel cancer therapeutics.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Dec 14, 2022 | Series B | $30M | 8 |
Cambridge Innovation Capital
Fast Track Initiative, Inc.
M Ventures
Pfizer Venture Investments
Taiho Ventures
UTokyo Innovation Platform
|
— | Detail |
| May 3, 2022 | Grant | — | 1 |
Innovate UK
|
— | Detail |
| May 20, 2019 | Series A | £14M | 6 |
Seroba Life Sciences
|
— | Detail |
| Sep 3, 2018 | Grant | £240K | 1 |
Innovate UK
|
— | Detail |
| Jan 8, 2018 | Series A | £4M | 1 |
Taiho Ventures
|
— | Detail |
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Cambridge Innovation Capital
|
Yes | Series B |
Fast Track Initiative, Inc.
|
Yes | Series B |
M Ventures
|
Yes | Series B |
Pfizer Venture Investments
|
Yes | Series B |
Taiho Ventures
|
Yes | Series B |
UTokyo Innovation Platform
|
Yes | Series B |
Innovate UK
|
Yes | Grant |
IP Group
|
— | Series B |
Seroba Life Sciences
|
— | Series B |
Imperial Innovations
|
— | Series A |